Skip to main content
Utility menu
Donate
Join
Member Login
Search
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Careers
Support The Mission
Support The Mission
Become a Member
Explore Different Ways to Give
Create a Legacy
Join IASLC's Partners for Thoracic Cancer Care
Recognizing Our Donors
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
WCLC 2024 Highlights
Access Online Learning
Conferences & Education
Conferences & Education
Conferences
Webinars
Online Learning: Lung Cancer 360
Lung Cancer Considered Podcast
WCLC 2024
Science & Research
Science & Research
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Research Grant Program
Research Grant Program
Research Grant Recipients
IASLC Academy
Publications, Resources & Guidelines
Membership
Membership
Become a Member
Renew Your Membership
Early-Career Opportunities
Partners Society Membership Offers
Patients & Caregivers
Patients & Caregivers
STARS Training
Lung Cancer Awareness Month
News
News
IASLC Lung Cancer News
WCLC 2024 News
Press Releases
Search
Fulltext search
Fulltext search
Search
Displaying 1 - 12 items out of 314 results
ILCN article
Pembrolizumab Plus Platinum-Doublet Chemotherapy and Concurrent Radiotherapy as First-Line Treatment for Unresectable, Locally Advanced Stage III NSCLC: The KEYNOTE-799 Trial in Perspective
ILCN article
Intratumoral Dendritic Cells in Treatment of Lung Cancer
ILCN article
Comprehensive Analysis of Proteomics Identifies New, Druggable Drivers of NSCLC—and New Avenue for Continued Research
ILCN article
The eNRGy1 Global Multicenter Registry: NRG1 Fusions as a Hidden Target in Lung Cancer
ILCN article
Question Literature’s Face Value
ILCN article
Gemcitabine: A New Chemotherapy Partner for Immune Checkpoint Inhibitors? Insights From the ORIENT-12 Study
ILCN article
Telehealth Struggles to Find Permanent Footing After Rapid Growth During Pandemic
ILCN article
Therapeutic Vaccine Development in Lung Cancer: Update and Recent Advances
ILCN article
Economics of Locally Advanced Lung Cancer Before and During COVID-19 Pandemic: A Perspective for Developing Countries
ILCN article
Ablation Techniques for Lung Nodules: Percutaneous or Transbronchial Approach?
ILCN article
Dr. Patrick Forde Discusses Excitement Around Neoadjuvant Immunotherapy for Lung Cancer
ILCN article
Addition of Nivolumab to Neoadjuvant Chemotherapy in NSCLC: Results of CheckMate-816
Pagination
1
2
3
4
5
6
7
8
9
…
›
Next page
Last
Last page